8H78 | pdb_00008h78

Crystal structure of human MMP-2 catalytic domain in complex with inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free: 
    0.319 (Depositor), 0.322 (DCC) 
  • R-Value Work: 
    0.265 (Depositor), 0.270 (DCC) 
  • R-Value Observed: 
    0.268 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8H78

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Discovery of TP0597850: A Selective, Chemically Stable, and Slow Tight-Binding Matrix Metalloproteinase-2 Inhibitor with a Phenylbenzamide-Pentapeptide Hybrid Scaffold.

Takeuchi, T.Nomura, Y.Tamita, T.Nishikawa, R.Kakinuma, H.Kojima, N.Hitaka, K.Tamura, Y.Kamitani, M.Mima, M.Nozoe, A.Hayashi, M.

(2023) J Med Chem 66: 822-836

  • DOI: https://doi.org/10.1021/acs.jmedchem.2c01698
  • Primary Citation Related Structures: 
    8H78

  • PubMed Abstract: 

    Matrix metalloproteinase-2 (MMP2) is a zinc-dependent endopeptidase and a promising target for various diseases, including cancer and fibrosis. Herein, we report the discovery of a novel MMP2-selective inhibitor with high chemical stability and slow tight-binding features. Based on the degradation mechanism of our small-molecule-peptide hybrid 1 , the tripeptide linker {5-aminopentanoic acid [Ape(5)]-Glu-Asp} of 1 was replaced by a shorter linker (γ-D-Glu). Phenylbenzamide was suitable for the new generation of MMP2 inhibitors as an S1' pocket-binding group. The introduction of (4 S )-aminoproline dramatically increased the chemical stability while maintaining high subtype selectivity because of its interaction with Glu130. TP0597850 ( 18 ) exhibited high stability over a wide range of pH values as well as potent MMP2 inhibition ( K i = 0.034 nM) and ≥2000-fold selectivity determined using the inhibition constants. A kinetic analysis revealed that it possesses slow tight-binding nature with a long MMP2 dissociative half-life ( t 1/2 = 265 min).


  • Organizational Affiliation
    • Taisho Pharmaceutical Co., Ltd., Saitama331-9530, Japan.

Macromolecule Content 

  • Total Structure Weight: 40.05 kDa 
  • Atom Count: 2,804 
  • Modeled Residue Count: 335 
  • Deposited Residue Count: 336 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Matrix metalloproteinase-2
A, B
168Homo sapiensMutation(s): 0 
Gene Names: MMP2
EC: 3.4.24.24
UniProt & NIH Common Fund Data Resources
Find proteins for P08253 (Homo sapiens)
Explore P08253 
Go to UniProtKB:  P08253
PHAROS:  P08253
GTEx:  ENSG00000087245 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP08253
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
L2U
(Subject of Investigation/LOI)

Query on L2U



Download:Ideal Coordinates CCD File
I [auth A],
O [auth B]
(2~{R})-2-[[4-[(4-aminocarbonylphenyl)carbonylamino]phenyl]sulfonylamino]-5-[(2~{S},4~{S})-4-azanyl-2-[[(2~{S})-1-[[(2~{S})-1-[(5-azanyl-5-oxidanylidene-pentyl)amino]-5-oxidanyl-1,5-bis(oxidanylidene)pentan-2-yl]-methyl-amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamoyl]pyrrolidin-1-yl]-5-oxidanylidene-pentanoic acid
C41 H57 N9 O13 S
XGGNDAOPHPLHFW-PVNIVXITSA-N
2HP

Query on 2HP



Download:Ideal Coordinates CCD File
H [auth A]DIHYDROGENPHOSPHATE ION
H2 O4 P
NBIIXXVUZAFLBC-UHFFFAOYSA-M
ZN

Query on ZN



Download:Ideal Coordinates CCD File
C [auth A],
D [auth A],
J [auth B],
K [auth B]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
CA

Query on CA



Download:Ideal Coordinates CCD File
E [auth A]
F [auth A]
G [auth A]
L [auth B]
M [auth B]
E [auth A],
F [auth A],
G [auth A],
L [auth B],
M [auth B],
N [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N
Binding Affinity Annotations 
IDSourceBinding Affinity
L2U BindingDB:  8H78 Ki: 0.03 (nM) from 1 assay(s)
IC50: min: 0.03, max: 0.22 (nM) from 2 assay(s)

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.40 Å
  • R-Value Free:  0.319 (Depositor), 0.322 (DCC) 
  • R-Value Work:  0.265 (Depositor), 0.270 (DCC) 
  • R-Value Observed: 0.268 (Depositor) 
Space Group: I 41
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 79.683α = 90
b = 79.683β = 90
c = 127.434γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
CrysalisProdata reduction
CrysalisProdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Not funded--

Revision History  (Full details and data files)

  • Version 1.0: 2023-01-18
    Type: Initial release
  • Version 1.1: 2023-01-25
    Changes: Database references
  • Version 1.2: 2023-11-29
    Changes: Data collection, Refinement description